VarCov Co’s Oric Pharmaceuticals ORIC Stock Holding History

VarCov Co’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,036	Closed	-$262K	–	565
2025 Q4	$262K	Buy	+32,036	New	+$369K	0.1%	328

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

VarCov Co's ORIC Position: Q1 2026 in Review

VarCov Co sold out of Oric Pharmaceuticals (ORIC) in Q1 2026, closing a stake of 32,036 shares — an estimated $262K sold.

VarCov Co first reported a position in ORIC in Q4 2025 and held it in 1 quarter. The position peaked at $262K in Q4 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

VarCov Co reported no remaining Oric Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 32,036 Oric Pharmaceuticals shares in Q1 2026, an estimated $262K.
VarCov Co first reported a position in Oric Pharmaceuticals in Q4 2025 and held it in 1 quarter.
VarCov Co's Oric Pharmaceuticals position peaked at $262K in Q4 2025.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.